Your account is not claimed yet. You can sign up with ORCID to claim your account.

Kun-Ho Yoon (Kun Ho Yoon)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 25

Top Venues

Diabetes, obesity & metabolism

Journal of diabetes investigation

Diabetes & metabolism journal

Diabetes/metabolism research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Joonyub Lee, Kun-Ho Yoon
β cell replacement therapy for the cure of diabetes. Journal of diabetes investigation 13 (11) (2022)
Eun Young Lee, Seon-Ah Cha, Jae-Seung Yun, Sun-Young Lim, Jin-Hee Lee, Yu-Bae Ahn, Kun-Ho Yoon, Min Kyung Hyun, Seung Hyun Ko
Efficacy of Personalized Diabetes Self-care Using an Electronic Medical Record-Integrated Mobile App in Patients With Type 2 Diabetes: 6-Month Randomized Controlled Trial. Journal of medical Internet research 24 (7) (2022)
Eun Young Lee, Kun-Ho Yoon
Fighting the uphill battle to cure type 1 diabetes. Journal of diabetes investigation 12 (9) (2021)
Joonyub Lee, Kun-Ho Yoon
Diabetes duration and obesity matter in autologous mesenchymal stem/stromal cell transplantation in type 2 diabetes patients. Journal of diabetes investigation (2021)
Hyunah Kim, Seung-Hwan Lee, Hyunyong Lee, Hyeon Woo Yim, Jae-Hyoung Cho, Kun-Ho Yoon, Hun Sung Kim
Blood glucose levels and bodyweight change after dapagliflozin administration. Journal of diabetes investigation 12 (9) (2021)
Wayne Huey Herng Sheu, Siew Pheng Chan, Bien J Matawaran, Chaicharn Deerochanawong, Ambrish Mithal, Juliana Chan, Ketut Suastika, Chin Meng Khoo, Huu Man Nguyen, Ji Linong, Andrea Luk, Kun-Ho Yoon
Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations. Diabetes & metabolism journal 44 (1) (2021)
Yeoree Yang, Kyung Do Han, Sang-Hyun Park, Mee Kyoung Kim, Kun-Ho Yoon, Seung Hwan Lee
High-Density Lipoprotein Cholesterol and the Risk of Myocardial Infarction, Stroke, and Cause-Specific Mortality: a Nationwide Cohort Study in Korea. Journal of lipid and atherosclerosis 10 (1) (2020)
Kun-Ho Yoon, Jahoon Kang, Se Chang Kwon, Michael E Trautmann, Marcus Hompesch, John Stewart, Christopher H Sorli
Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes. Diabetes, obesity & metabolism 22 (8) (2020)
Yun-Jung Cho, Kun-Ho Yoon
Being caught in the perfect storm of a diabetes epidemic and the COVID-19 pandemic: What should we do for our patients? Journal of diabetes investigation 12 (3) (2020)
Seon-Ah Cha, Suk Chon, Jae-Seung Yun, Sang Youl Rhee, Sun-Young Lim, Kun-Ho Yoon, Yu-Bae Ahn, Seung Hyun Ko, Jeong Taek Woo, Jin-Hee Lee
Optimal fasting plasma glucose and haemoglobin A1c levels for screening of prediabetes and diabetes according to 2-hour plasma glucose in a high-risk population: The Korean Diabetes Prevention Study. Diabetes/metabolism research and reviews (2020)
Kyu Chang Won, Kun-Ho Yoon
The Outbreak of COVID-19 and Diabetes in Korea: "We Will Find a Way as We Have Always Done". Diabetes & metabolism journal 44 (2) (2020)
Yeoree Yang, Ji-Won Kim, Heon-Seok Park, Eun-Young Lee, Kun-Ho Yoon
Pancreatic stellate cells in the islets as a novel target to preserve the pancreatic β-cell mass and function. Journal of diabetes investigation 11 (2) (2020)
Stephano Del Prato, Jahoon Kang, Michael E Trautmann, John Stewart, Christopher H Sorli, Michael Derwahl, Alfonso Soto, Kun-Ho Yoon
Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study. Diabetes, obesity & metabolism 22 (7) (2020)
Chin Meng Khoo, Chaicharn Deerochanawong, Siew Pheng Chan, Bien Matawaran, Wayne Huey Herng Sheu, Juliana Chung Ngor Chan, Ambrish Mithal, Andrea On Yan Luk, Ketut Suastika, Kun-Ho Yoon, Li-Nong Ji, Nguyen Huu Man, Carol Pollock
Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations. Diabetes, obesity & metabolism 23 (2) (2020)
Junghyun Noh, Hyun Ha Chang, In-Kyung Jeong, Kun-Ho Yoon
Coronavirus Disease 2019 and Diabetes: The Epidemic and the Korean Diabetes Association Perspective. Diabetes & metabolism journal 44 (3) (2020)
Sin Gon Kim, Kyoung Jin Kim, Kun-Ho Yoon, Sung Wan Chun, Kyong Soo Park, Kyung Mook Choi, Soo Lim, Ji-Oh Mok, Hyoung Woo Lee, Ji A Seo, Bong Soo Cha, Mi Kyung Kim, Ho Sang Shon, Dong Seop Choi, Doo-Man Kim
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks. Diabetes, obesity & metabolism 22 (10) (2020)
Alice Pik-Shan Kong, Thomas Lew, Eric S H Lau, Lee-Ling Lim, Jothydev Kesavadev, Weiping Jia, Wayne Huey Herng Sheu, Leorino Sobrepena, Alexander T B Tan, Thy Khue Nguyen, Kun-Ho Yoon, Ke Wang, Kamlanathan Kodiappan, Tamás Treuer, Juliana Chung Ngor Chan, null null
Real-world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register. Diabetes, obesity & metabolism 22 (4) (2020)
Li-Nong Ji, Juliana Chung Ngor Chan, Miao Yu, Kun-Ho Yoon, Sin Gon Kim, Sung Hee Choi, Chien-Ning Huang, Shih Te Tu, Chih-Yuan Wang, Päivi Maria Paldánius, Wayne Huey Herng Sheu
Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective. Diabetes, obesity & metabolism 23 (1) (2020)
Yeoree Yang, Eun Young Lee, Hun Sung Kim, Seung Hwan Lee, Kun-Ho Yoon, Jae-Hyoung Cho
Effect of a Mobile Phone-Based Glucose-Monitoring and Feedback System for Type 2 Diabetes Management in Multiple Primary Care Clinic Settings: Cluster Randomized Controlled Trial. JMIR mHealth and uHealth 8 (2) (2020)
Richard E Pratley, Jahoon Kang, Michael E Trautmann, Marcus Hompesch, OakPil Han, John Stewart, Christopher H Sorli, Stephan Jacob, Kun-Ho Yoon
Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study. Diabetes, obesity & metabolism 21 (11) (2019)
Chaicharn Deerochanawong, Siew P Chan, Bien J Matawaran, Wayne Huey Herng Sheu, Juliana Chan, Nguyen H Man, Ketut Suastika, Chin M Khoo, Kun-Ho Yoon, Andrea On Yan Luk, Ambrish Mithal, Li-Nong Ji
Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations. Diabetes, obesity & metabolism 21 (11) (2019)
You Cheol Hwang, Se Won Kim, Kyu-Yeon Hur, Bong Soo Cha, In Joo Kim, Tae Sun Park, Sei Hyun Baik, Kun-Ho Yoon, Kwan-Woo Lee, In-Kyu Lee, Moon Kyu Lee
Predictive Factors for Efficacy of AST-120 Treatment in Diabetic Nephropathy: a Prospective Single-Arm, Open-Label, Multi-Center Study. Journal of Korean medical science 34 (15) (2019)
Hae Kyung Yang, Seung Hwan Lee, Juyoung Shin, Yoon Hee Choi, Yu Bae Ahn, Byung Wan Lee, Eun Jung Rhee, Kyung Wan Min, Kun-Ho Yoon
Acarbose Add-on Therapy in Patients with Type 2 Diabetes Mellitus with Metformin and Sitagliptin Failure: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Diabetes & metabolism journal 43 (3) (2018)
Seung Hwan Lee, Marie Rhee, Hyuk Sang Kwon, Yong Moon Park, Kun-Ho Yoon
Serum Betatrophin Concentrations and the Risk of Incident Diabetes: A Nested Case-Control Study from Chungju Metabolic Disease Cohort. Diabetes & metabolism journal 42 (1) (2017)
Kun-Ho Yoon, Elise Hardy, Jenny Han
Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus. Diabetes & metabolism journal 41 (1) (2016)

Kun-Ho Yoon.css-eqlu8i{font-size:small;padding-left:4px;} (Kun Ho Yoon)

Publication Activity (10 Years)

Top Topics

Top Venues

Kun-Ho Yoon (Kun Ho Yoon)